277 related articles for article (PubMed ID: 37859591)
1. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review).
Pekarek L; Garrido-Gil MJ; Sánchez-Cendra A; Cassinello J; Pekarek T; Fraile-Martinez O; García-Montero C; Lopez-Gonzalez L; Rios-Parra A; Álvarez-Mon M; Acero J; Diaz-Pedrero R; Ortega MA
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859591
[TBL] [Abstract][Full Text] [Related]
2. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
3. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma hsa_circ_0000190 and 0001649 as biomarkers for predicting the recurrence and treatment response of patients with oral squamous cell carcinoma.
Hung KF; Chen BH; Wang TY; Yang YP; Chien Y; Lo JF; Yang L; Peng BY; Kao SY; Wu CH
J Chin Med Assoc; 2022 Apr; 85(4):431-437. PubMed ID: 35125403
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the current MicroRNAs expression levels as potential biomarkers in Oral Squamous Cell Carcinoma.
Tahmasebi E; Kaboudanian Ardestani A; Madihi N; Abbasiparashkouh Z; Abbasi Maleki S; Yazdanian M; Khafaei M; Movafagh A; Tavallaie M
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):193-198. PubMed ID: 37114250
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges.
Yu T; Li C; Wang Z; Liu K; Xu C; Yang Q; Tang Y; Wu Y
Clin Transl Oncol; 2016 May; 18(5):427-36. PubMed ID: 26370423
[TBL] [Abstract][Full Text] [Related]
7. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
8. An Oral Microbial Biomarker for Early Detection of Recurrence of Oral Squamous Cell Carcinoma.
Lyu WN; Lin MC; Shen CY; Chen LH; Lee YH; Chen SK; Lai LC; Chuang EY; Lou PJ; Tsai MH
ACS Infect Dis; 2023 Sep; 9(9):1783-1792. PubMed ID: 37565768
[TBL] [Abstract][Full Text] [Related]
9. Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review.
Wang S; Yang M; Li R; Bai J
Eur J Med Res; 2023 Jan; 28(1):53. PubMed ID: 36707844
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
De Paz D; Kao HK; Huang Y; Chang KP
Curr Oncol Rep; 2017 Aug; 19(10):65. PubMed ID: 28799122
[TBL] [Abstract][Full Text] [Related]
11. Mutation detection in saliva from oral cancer patients.
Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
[TBL] [Abstract][Full Text] [Related]
12. MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.
Krishnan M; Babu S; Jayaraman S; Daniel P; Solomon A; Chinnaiyan M
Exp Oncol; 2022 Nov; 44(3):263-264. PubMed ID: 36325699
[No Abstract] [Full Text] [Related]
13. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
14. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma: diagnostic markers and prognostic indicators.
Lauritano D; Lucchese A; Contaldo M; Serpico R; Lo Muzio L; Biolcati F; Carinci F
J Biol Regul Homeost Agents; 2016; 30(2 Suppl 1):169-76. PubMed ID: 27469565
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma - progresses from risk assessment to treatment.
Mao L
Chin J Dent Res; 2012; 15(2):83-8. PubMed ID: 23509828
[TBL] [Abstract][Full Text] [Related]
17. The promising impact of molecular profiling on treatment strategies in oral cancers.
Foy JP; Saintigny P; Goudot P; Schouman T; Bertolus C
J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):242-247. PubMed ID: 28576460
[TBL] [Abstract][Full Text] [Related]
18. Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route.
Panarese I; Aquino G; Ronchi A; Longo F; Montella M; Cozzolino I; Roccuzzo G; Colella G; Caraglia M; Franco R
Expert Rev Anticancer Ther; 2019 Feb; 19(2):105-119. PubMed ID: 30582397
[TBL] [Abstract][Full Text] [Related]
19. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
20. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
